Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Stock price
Equities
600196
CNE000000X38
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.1 CNY | +1.41% | +1.37% | +0.28% |
Mar. 14 | Shanghai Fosun Pharma Unit's Oral Schizophrenia Drug Gets Marketing Registration | MT |
Mar. 08 | Fosun Pharma Unit Gets China OK for Phase I Trial for Solid Tumor Drug | MT |
Sales 2023 * | 41.59B 5.78B | Sales 2024 * | 45.71B 6.35B | Capitalization | 60.62B 8.42B |
---|---|---|---|---|---|
Net income 2023 * | 3.25B 452M | Net income 2024 * | 4.22B 587M | EV / Sales 2023 * | 1.71 x |
Net Debt 2023 * | 10.66B 1.48B | Net Debt 2024 * | 12.78B 1.78B | EV / Sales 2024 * | 1.61 x |
P/E ratio 2023 * |
20.2
x | P/E ratio 2024 * |
15.9
x | Employees | 38,399 |
Yield 2023 * |
1.45% | Yield 2024 * |
1.76% | Free-Float | 63.41% |
1 day | +1.41% | ||
1 week | +1.37% | ||
Current month | +2.12% | ||
1 month | +4.80% | ||
3 months | +0.04% | ||
6 months | -12.24% | ||
Current year | +0.28% |
Managers | Title | Age | Since |
---|---|---|---|
De Yong Wen
CEO | Chief Executive Officer | 52 | - |
Dong Ming Li
PSD | President | 55 | 20-10-28 |
Yi Fang Wu
CHM | Chairman | 54 | 04-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fang Yao
BRD | Director/Board Member | 54 | 10-04-08 |
Qi Yu Chen
BRD | Director/Board Member | 51 | 94-03-31 |
Xiao Hui Guan
BRD | Director/Board Member | 53 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.27% | 2 M€ | -10.16% | - | |
1.18% | 4 M€ | -2.96% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 25.1 | +1.41% | 12,708,200 |
24-03-15 | 24.75 | -0.68% | 11,822,980 |
24-03-14 | 24.92 | +0.77% | 21,132,940 |
24-03-13 | 24.73 | -1.20% | 11,008,830 |
24-03-12 | 25.03 | +1.09% | 14,990,620 |
End-of-day quote Shanghai S.E., March 17, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.28% | 8.32B | |
+30.83% | 679B | |
+30.96% | 589B | |
+0.01% | 381B | |
+15.18% | 314B | |
+11.39% | 308B | |
+0.78% | 212B | |
-6.09% | 210B | |
-2.92% | 203B | |
-3.72% | 158B |